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In the early stages of a drug discovery project it is often
necessary to narrow down the search space for potential
new leads substantially [1,2]. This crucial step identifies
a set of molecules (a hit series) that have a high likeli-
hood of being relevant to the drug discovery project. In
many cases high throughput screening (HTS) is used to
test (in-vitro) large amounts of molecules against a bio-
logical target in order to validate a molecule’s potential
to interact with the target and therewith its relevance to
the drug discovery process. Since there are time and
money constraints associated with such a process, it is
not feasible to pipe the full HTS compound set through
very detailed testing. Rather, an HTS process consists of
several stages: a primary (spot test, SP) stage, a confir-
mation (retest) stage and a concentration-response (CR)
stage. The later is the most resource-intensive where
compounds are tested at a range of different concentra-
tions, which allows for curve-fitting and determination
of the potencies.
The HTS Explorer enables HTS evaluators across
AstraZeneca R&D sites to do a comprehensive and effec-
tive screening analysis for compound prioritization
within a single tool. This tool is provided as an extension
to the visualization platform TIBCO Spotfire [3]. The use
of Spotfire as a platform streamlines the process for the
HTS evaluator and facilitates distribution of the tool as
sharing of the HTS data evaluations. Further new
approaches and methods can be made easily and readily
available across AZ. Data is retrieved by calling Pipeline-
Pilot protocols, various web-services and queries to in-
house databases [4,5]. The main features include many
different options for clustering of compounds as well as
commenting on clusters, cluster visualization, prioritiza-
tion and interactive reclustering. Further it enables com-
pound annotation with e.g. the known Structure-Activity
Relationship (SAR) space and offers different types of
structural searches in internal and external databases.
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